Adult Stem Cell Therapy for Rheumatoid Arthritis | Okyanos Cell Therapy

Because RA causes debilitating pain and progressive damage, early and aggressive treatment is vital. Conventional rheumatoid arthritis (RA) treatment cannot reverse the damage done to your joints over time, however Okyanos Cell Therapy presents a unique opportunity for healing and pain relief across a spectrum of lasting benefits.

Utilizing the powerful stem and regenerative cells which already exist in your body fat, stem cell therapy for rheumatoid arthritis addresses the pain and inflammation associated with RA while encouraging the repair of damaged joints and tissue, to help you get back to a more normal life.

What is RA?

Rheumatoid arthritis is an autoimmune disease wherein the immune system mistakenly attacks your joints (most commonly the joints of your hands, feet, wrists, elbows, knees and ankles.) RA causes painful swelling to your joints as well as destruction of the cartilage or cushioning between your bones and a weakening of the surrounding muscles, ligaments and tendons, all of which can make it very difficult to move.

Some patients with RA experience persistent joint damage and pain, while others alternate between flare-ups and periods of remission. This condition may also lead to microvascular dysfunction and severe cardiovascular risk as well as feelings of helplessness—thus greatly impacting your overall quality of life.

Targeting Rheumatoid Arthritis Damage at the Source

Your body fat, or adipose tissue, possesses an abundant source of adult stem cells (among other powerful, healing cells). These cells, known as mesenchymal stem cells (MSCs), are often referred to as small doctors for their ability to diagnose, treat and repair dysfunction in the body.

MSCs are particularly effective in treating autoimmune disorders like RA because they are able not only to promote the repair of damage caused to the joints, but also to halt destructive immune system response and thus prevent future damage from continuing to occur.

Clinical research has shown that MSCs can offer lasting benefit or at least some relief to patients with RA as well as addressing microvascular complications by carrying out the important jobs of:

  • Improving blood flow
  • Reducing inflammation
  • Repairing and replacing damaged tissue

The Procedure

Stem cell therapy for rheumatoid arthritis at Okyanos is a safe, minimally invasive, same-day outpatient procedure with very little recovery or down time needed.

  1. First, water-assisted fat harvesting is done to obtain about 20 ounces of adipose (fat) tissue from your hip or abdomen
  2. A unique blend of stem and regenerative cells are separated from your fat tissue and prepared for injection using either or both of the Cytori Celution® and Lipogems® Cell Processing Systems.
  3. Your adult stem cells are then delivered intravenously as well as by direct injection to affected joints according to your individualized treatment plan.

To learn more about Okyanos Cell Therapy for your RA, contact a Patient Liaison to request a complimentary educational consultation or dial 855-OKYANOS (855-659-2667).


Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis (January 2010) in Annals of the Rheumatic Diseases. Retrieved from

What is Rheumatoid Arthritis? Arthritis Foundation. Retrieved from July, 2015

National Institute of Arthritis and Musculoskeletal and Skin Diseases. Retrieved from July, 2015

Treatment of Experimental Arthritis by Inducing Immune Tolerance With Human Adipose-Derived Mesenchymal Stem Cells (April 2009) in Arthritis and Rheumatism. Retrieved from

Application of Stem Cells in Orthopedics (2012) in Stem Cells International, volume 2012 article ID 394962. Retrieved from

Fat Tissue: An Underappreciated Source of Stem Cells for Biotechnology (April, 2006) in Trends in Biotechnology. Retrieved from

Mesenchymal Stem Cells in Arthritic Diseases (October 10, 2008) in Arthritis Research & Therapy. Retrieved from

Clinical Applications of Mesenchymal Stem Cells in Chronic Diseases (30 April 2014) in Stem Cells International. Retrieved from

Clinical Applications of Mesenchymal Stem Cells (30 April 2012) in Journal of Hematology and Oncology. Retrieved from

Stem Cell Technology for Bone Regeneration: Current Status and Potential Applications (February 10, 2015) in Stem Cells Cloning. Retrieved from:

Inflammatory Suppression Rapidly Attenuates Microvascular Dysfunction in Rheumatoid Arthritis (June, 2007) in Atherosclerosis. Retrieved from

C-reactive Protein: The Underlying Cause of Microvascular Dysfunction in Rheumatoid Arthritis (2008) in Rhematology. Retrieved from: